Dr Reddy’s announce launch of Sputnik V vaccine in Indian market
The first dose of the vaccine was administered in Hyderabad
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
Over two billion doses of COVID-19 vaccines to be available between August to December 2021: Centre…
Dr V K Paul said by the first quarter of the next year, the number is likely to be three billion
NTAGI recommends gap of 12-16 weeks between doses of Covishield
It has also suggested that pregnant women may be offered the choice to take any COVID-19 vaccine and that lactating women can be…
IDMA supports patent waiver for vaccines to ramp up production
Urges global pharma companies to grant voluntary licenses (VL) and transfer technology of vaccines to Indian companies against…
Lilly signs licensing agreements with Dr Reddy’s, MSN Labs and Torrent Pharma for Baricitinib
On May 10, Lilly had also announced the signing of three Voluntary License Agreements with Cipla, Lupin and Sun Pharma Industries
Govt in talks with manufacturers to ramp up availability of Amphotericin B to treat Mucormycosis
States have been requested to put in place a mechanism for equitable distribution of supplies amongst government and private…
SEC recommends phase II/III clinical trials of Covaxin on 2-18 year-olds
The trial will be conducted on 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of…
Virafin from Zydus Cadila priced at Rs 11,995 per dose
The company has commenced dispatching the drug which can reportedly reduce oxygen support in COVID-19 patients, as per reports
Kejriwal asks PM to share vaccine formula with pharma firms to ramp up manufacturing
He said the Centre can also terminate the monopoly on vaccine production through the patent law
Novavax postpones timelines for COVID-19 vaccine production, regulatory authorisations
The company has repeatedly pushed back production forecasts and has struggled to access raw materials and equipment needed to make…
Pfizer, BioNTech get US FDA nod for emergency use of COVID-19 vaccine in adolescents
This is the first COVID-19 vaccine authorised in the US for use in this age group
COVID strain identified in India is ‘variant of concern’: WHO
Dr Maria Van Kerkhove, COVID-19 Technical Lead at the WHO said some preliminary studies demonstrate that there is increased…
States must ensure special teams to prevent black marketing of drugs: Centre to SC
The Centre said that the DCGI has instructed the state governments that there should be zero tolerance to any kind of hoarding or…
Bharat Biotech begins direct supply of COVAXIN to 14 states
The firm has started supplying its COVID-19 vaccine to the states based on the allocations received by the central government
Vaccination is the only long-term solution to COVID-19 crisis in India: Fauci
He called for scaling up manufacturing of coronavirus vaccines both domestically and globally to fight the deadly pandemic
Vivimed gets DGHI nod to manufacture, market favipiravir tablet in India
The drug will be marketed under Vivimed’s brand name ‘Favulous’ across India
Lilly signs licensing agreements with Cipla, Lupin and Sun Pharma for Baricitinib in India
Lilly has recently received permission for restricted emergency use by CDSCO for baricitinib to be used in combination with…
Cipla signs licensing deal with Lilly to manufacture and commercialise baricitinib in India
Baricitinib was issued a restricted emergency use approval by CDSCO to treat COVID-19
DCGI nod for anti-COVID 19 drug developed by DRDO
Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental…
Biological E. to begin Phase III trial of COVID-19 vaccine
The company plans to produce 75 million to 80 million doses a month from August